bioAffinity Technologies (BIAF) Receivables: 2022-2025
Historic Receivables for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to $476,133.
- bioAffinity Technologies' Receivables fell 65.41% to $476,133 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 40.03%. This contributed to the annual value of $1.2 million for FY2024, which is 38.74% up from last year.
- As of Q3 2025, bioAffinity Technologies' Receivables stood at $476,133, which was up 7.87% from $441,385 recorded in Q2 2025.
- bioAffinity Technologies' Receivables' 5-year high stood at $1.7 million during Q2 2024, with a 5-year trough of $9,930 in Q3 2022.
- Its 3-year average for Receivables is $853,859, with a median of $981,125 in 2025.
- Per our database at Business Quant, bioAffinity Technologies' Receivables surged by 11,109.91% in 2023 and then crashed by 74.26% in 2025.
- Quarterly analysis of 4 years shows bioAffinity Technologies' Receivables stood at $20,978 in 2022, then skyrocketed by 3,910.04% to $841,227 in 2023, then surged by 38.74% to $1.2 million in 2024, then plummeted by 65.41% to $476,133 in 2025.
- Its last three reported values are $476,133 in Q3 2025, $441,385 for Q2 2025, and $981,125 during Q1 2025.